Real-world clinical and budget impact of semaglutide in type 2 diabetes mellitus in tertiary hospital in Saudi Arabia

Key Points

• Significant improvement in glycemic control was observed with semaglutide treatment, enhancing patient health outcomes significantly.
• Weight-loss control also improved notably, showcasing the effectiveness of semaglutide in managing obesity linked with T2DM.
• Cost analysis revealed that the overall budget impact was higher due to the medication costs associated with semaglutide treatment.
• While benefits for health are highlighted, this emphasizes the need for budget considerations in treatment planning.